Kedaara Capital Acquires Majority Stake in Tynor for $200 Million

Kedaara Capital has made a strategic investment by acquiring a 51% stake in Tynor Orthotics, an established Indian manufacturer of orthopaedic supports and rehabilitation products, for $200 million. This acquisition marks a significant expansion of Kedaara's medical devices portfolio, reflecting its confidence in the rapid growth of India's healthcare sector.

Strategic Partnership and Expansion Plans

Tynor Orthotics, founded in 1993 and headquartered in Mohali, is renowned for its comprehensive range of products, including orthopaedic supports, mobility aids, and sports performance equipment. The company boasts a robust distribution network that spans over 300,000 retail outlets and 8,000 hospitals across 60 countries, with products reaching more than 100 million people globally.

Kedaara Capital's partnership with Tynor will involve collaboration with the company’s promoters, Dr. P.J. Singh and A.J. Singh, its professional management team, and the French orthopaedic company Thuasne, which has been a strategic partner since 2010. This alliance aims to bolster Tynor's presence both in India and internationally, enhance its manufacturing capabilities, and develop a broader orthopaedic and wellness platform.

Market Potential and Industry Growth

The Indian medical devices sector is one of the fastest-growing markets globally, offering lucrative opportunities for investors. Sunish Sharma, founder and managing partner at Kedaara Capital, emphasized that Tynor represents a unique opportunity to partner with a leader in the orthopaedic supports and rehabilitation sector. The investment is poised to capitalize on the increasing demand for medical devices in India, driven by a growing focus on healthcare and wellness.

Tynor's manufacturing operations are supported by three facilities that prioritize lean manufacturing and globally compliant production standards. This focus on quality and efficiency positions the company well to meet the rising demand in both domestic and international markets.

Advisory and Financial Details

The financial advisory for the transaction was exclusively managed by O3 Capital, which facilitated the deal between Kedaara Capital and Tynor Orthotics. The investment underscores the private equity firm's strategic interest in expanding its presence in the healthcare sector, particularly in high-growth markets like India.

As Kedaara Capital integrates Tynor into its portfolio, the focus will be on leveraging Tynor's established brand and distribution network to maximize growth potential. This investment is expected to drive innovation and expansion in the orthopaedic market, benefiting from the synergies between Tynor's expertise and Kedaara's strategic vision.